LIAS mutations impairs mitochondrial energy metabolism [25] Moreover, high LIAS expression has been documented to be related to a favorable prognosis in patients with KIRC, rectal adenocarcinoma (READ), breast carcinoma, and ovarian carcinoma [26]. The gene discussed is LIAS; the disease is ovarian carcinoma.